Skip to main content
. 2007 Dec 5;14(3-4):175–183. doi: 10.2119/2007-00095.Alleva

Figure 5.

Figure 5

Clinical evaluation of wounds in LA-supplemented (LA-group) and control subjects (PL-group) undergoing HBO therapy. The area of lesions, calculated using the ‘mouse-eye’ software, was analyzed at 14 days (T14) and 40 days (T40) of HBO therapy. Data are expressed as percentage of area variation, evaluated at T14 and T40, and related to the basal value (T0) measured prior to the therapy.